Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine 2000 March;44(1)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,481


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1)

 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):1-2

Foreword

Bombardieri E.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):3-12

State of the art and future prospects in the management of neuroendocrine tumors

Öberg K.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):13-21

Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract

Rindi G., Capella C. *, Solcia E. **


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):22-41

Laboratory tests for neuroendocrine tumours

Seregni E., Ferrari L., Stivanello M., Dogliotti L.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):42-49

Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours

Chiti A., Briganti V. *, Fanti S. **, Monetti N. **, Masi R. *, Bombardieri E.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):50-8

New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy

Virgolini I., Traub T., Leimer M., Novotny C., Pangerl T., Ofluoglu S., Halvadjieva E., Smith-Jones P., Flores J., Li S. R., Angelberger P., Havlik E., Andreae F., Raderer M., Kurtaran A., Niederle B., Dudczak R.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):59-67

Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors

Adams S., Baum R. P.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):68-76

Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies

Eriksson B., Bergström M. *, Örlefors H., Sundin A. *,**, Öberg K., Långström B. *


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):77-87

Role of 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours. Experience of the National Cancer Institute of Milan

Castellani M. R., Chiti A., Seregni E., Bombardieri E.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):88-95

In situ radiotherapy with 111In-pentetreotide. State of the art and perspectives

McCarthy K. E., Woltering E. A. *, Anthony L. B. **


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 
FREEfree

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):96-101

New clinical trials for the treatment of neuroendocrine tumors

Bajetta E., Bichisao E., Artale S., Celio L., Ferrari L., Di Bartolomeo M., Zilembo N., Stani S. C., Buzzoni R.


top of page